首页> 外文期刊>Bone marrow transplantation >Generation of alloreactive anti-leukemic cytotoxic T lymphocytes with attenuated GVHD properties from haploidentical parents in childhood acute lymphoblastic leukemia.
【24h】

Generation of alloreactive anti-leukemic cytotoxic T lymphocytes with attenuated GVHD properties from haploidentical parents in childhood acute lymphoblastic leukemia.

机译:在儿童期急性淋巴细胞白血病中,单倍体父母产生具有变弱的GVHD特性的同种异体反应性抗白血病细胞毒性T淋巴细胞。

获取原文
获取原文并翻译 | 示例
       

摘要

We sought to generate alloreactive leukemia-reactive cytotoxic T lymphocytes from haploidentical parents by culture of peripheral blood mononuclear cells in vitro with irradiated leukemic blasts and IL-2 from children with ALL. After 21 days in culture the mean cytotoxicity of haploidentical lymphocytes against ALL blasts was 38% (n = 11). Cultured parental CTL were not leukemia specific but alloreactive as evidenced by equivalent cytotoxicity against stimulating ALL blasts and ConA-stimulated blasts from the other parent. The cultures yielded primarily CD8(+) T cells (59%). Irradiation of CTL limited proliferation by 96% but had no short-term effects on leukemia reactive cytotoxicity, suggesting a means to limit GVHD potential in vivo. One patient was treated for relapse of ALL post-haploidentical transplant with CTL generated from the original donor. A total of nine infusions were given: the first three were irradiated, while the last six were not due to disease progression. The patient experienced clearance of peripheral blasts, and despite concomitant infusion of IL-2 with the last three CTL infusions, did not experience immediate GVHD reactions. We conclude that ALL blasts are sufficiently immunostimulatory to generate in vitro CTL with provision of exogenous IL-2, and that these CTL could exert an anti-leukemia effect in vivo.
机译:我们试图通过用辐射的白血病母细胞和来自ALL患儿的IL-2在体外培养外周血单个核细胞,从单倍体亲本中产生同种异体反应性白血病反应性细胞毒性T淋巴细胞。培养21天后,单倍体淋巴细胞对ALL细胞的平均细胞毒性为38%(n = 11)。培养的亲本CTL不是白血病特异性的,而是同种异体反应,如对另一种亲本的刺激ALL胚和ConA刺激的胚具有同等的细胞毒性所证明。培养物主要产生CD8(+)T细胞(59%)。 CTL的辐射将增殖限制了96%,但对白血病的反应性细胞毒性没有短期影响,提示了一种限制体内GVHD潜力的方法。一名患者因原发供体产生的CTL进行了所有单倍体移植后复发的治疗。总共进行了9次输注:对前3次进行了辐照,而对后6次不是由于疾病进展。患者经历了周围胚泡的清除,尽管在最后三次CTL输注中同时注入了IL-2,但并未立即发生GVHD反应。我们得出的结论是,所有胚芽细胞都具有足够的免疫刺激性,可以在提供外源IL-2的条件下产生体外CTL,并且这些CTL可以在体内发挥抗白血病作用。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号